Literature DB >> 25583300

Single-tube methylation-specific duplex-PCR assay for rapid and accurate diagnosis of Fragile X Mental Retardation 1-related disorders.

Indhu-Shree Rajan-Babu1, Clara R L Teo, Mulias Lian, Caroline G Lee, Hai-Yang Law, Samuel S Chong.   

Abstract

AIM: Molecular diagnosis of fragile X syndrome demands assessment of fragile X mental retardation 1 (FMR1) CGG repeat size and methylation status, while predicting disease transmission risk requires determination of AGG interruption pattern. There is currently no single assay that provides all three categories of information. We describe a single-tube methylation-specific triplet-primed PCR assay for concurrently assessing methylation state, repeat size and structure of CGG repeat(s).
METHODS: Differentially labeled primers specific for methylated and unmethylated FMR1 alleles were used to amplify bisulfite-modified DNA, followed by capillary electrophoresis. Twenty-four reference DNAs and 107 patient samples were analyzed to evaluate assay performance.
RESULTS: Repeat size, AGG interruption pattern and methylation state were correctly identified in all tested samples. The assay also detected skewed X-inactivation when present in females, and somatic mosaicism in fragile X males.
CONCLUSION: When used in a molecular diagnostic setting, this novel assay could significantly minimize the need to reflex patient samples for Southern analysis.

Entities:  

Keywords:  AGG interruption; CGG repeat; FMR1; methylation; triplet-primed PCR

Mesh:

Substances:

Year:  2015        PMID: 25583300     DOI: 10.1586/14737159.2015.1001749

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  5 in total

1.  Identification of microsatellite markers <1 Mb from the FMR1 CGG repeat and development of a single-tube tetradecaplex PCR panel of highly polymorphic markers for preimplantation genetic diagnosis of fragile X syndrome.

Authors:  Min Chen; Mingjue Zhao; Caroline G Lee; Samuel S Chong
Journal:  Genet Med       Date:  2016-01-07       Impact factor: 8.822

Review 2.  Development of Genetic Testing for Fragile X Syndrome and Associated Disorders, and Estimates of the Prevalence of FMR1 Expansion Mutations.

Authors:  James N Macpherson; Anna Murray
Journal:  Genes (Basel)       Date:  2016-11-30       Impact factor: 4.096

3.  Validation of a commercially available test that enables the quantification of the numbers of CGG trinucleotide repeat expansion in FMR1 gene.

Authors:  Grace X Y Lim; Minli Yeo; Yvonne Y Koh; Tri Indah Winarni; Indhu-Shree Rajan-Babu; Samuel S Chong; Sultana M H Faradz; Ming Guan
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

Review 4.  Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related Disorders.

Authors:  Indhu-Shree Rajan-Babu; Samuel S Chong
Journal:  Genes (Basel)       Date:  2016-10-14       Impact factor: 4.096

Review 5.  FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome.

Authors:  Indhu-Shree Rajan-Babu; Mulias Lian; Felicia S H Cheah; Min Chen; Arnold S C Tan; Ethiraj B Prasath; Seong Feei Loh; Samuel S Chong
Journal:  Expert Rev Mol Med       Date:  2017-07-19       Impact factor: 5.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.